224 related articles for article (PubMed ID: 25007872)
1. Antagonism of the prostaglandin E2 EP1 receptor in MDCK cells increases growth through activation of Akt and the epidermal growth factor receptor.
Taub M; Parker R; Mathivanan P; Ariff MA; Rudra T
Am J Physiol Renal Physiol; 2014 Sep; 307(5):F539-50. PubMed ID: 25007872
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 increases proximal tubule fluid reabsorption, and modulates cultured proximal tubule cell responses via EP1 and EP4 receptors.
Nasrallah R; Hassouneh R; Zimpelmann J; Karam AJ; Thibodeau JF; Burger D; Burns KD; Kennedy CR; Hébert RL
Lab Invest; 2015 Sep; 95(9):1044-55. PubMed ID: 26121313
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.
Han C; Wu T
J Biol Chem; 2005 Jun; 280(25):24053-63. PubMed ID: 15855163
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection by PGE2 receptor EP1 inhibition involves the PTEN/AKT pathway.
Zhou P; Qian L; Chou T; Iadecola C
Neurobiol Dis; 2008 Mar; 29(3):543-51. PubMed ID: 18178094
[TBL] [Abstract][Full Text] [Related]
5. Function of prostaglandin E2 EP receptors in the acute outcome of rodent hypoxic ischemic encephalopathy.
Taniguchi H; Anacker C; Suarez-Mier GB; Wang Q; Andreasson K
Neurosci Lett; 2011 Oct; 504(3):185-90. PubMed ID: 21939736
[TBL] [Abstract][Full Text] [Related]
6. Involvement of EP1 and EP2 receptors in the regulation of the Na,K-ATPase by prostaglandins in MDCK cells.
Matlhagela K; Taub M
Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):101-13. PubMed ID: 16516814
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
Han C; Michalopoulos GK; Wu T
J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
9. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.
Michael JV; Gavrila A; Nayak AP; Pera T; Liberato JR; Polischak SR; Shah SD; Deshpande DA; Penn RB
FASEB J; 2019 Apr; 33(4):4780-4789. PubMed ID: 30601680
[TBL] [Abstract][Full Text] [Related]
10. EP1 receptor is involved in prostaglandin E2-induced osteosarcoma growth.
Niu JC; Ma N; Liu W; Wang PJ
Bosn J Basic Med Sci; 2019 Aug; 19(3):265-273. PubMed ID: 30995899
[TBL] [Abstract][Full Text] [Related]
11. The prostaglandin E2 receptor, EP2, stimulates keratinocyte proliferation in mouse skin by G protein-dependent and {beta}-arrestin1-dependent signaling pathways.
Chun KS; Lao HC; Langenbach R
J Biol Chem; 2010 Dec; 285(51):39672-81. PubMed ID: 20959465
[TBL] [Abstract][Full Text] [Related]
12. PGE
Gonzalez AA; Salinas-Parra N; Leach D; Navar LG; Prieto MC
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1038-F1049. PubMed ID: 28701311
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
[TBL] [Abstract][Full Text] [Related]
14. Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor.
Carlson NG; Rojas MA; Black JD; Redd JW; Hille J; Hill KE; Rose JW
J Neuroinflammation; 2009 Feb; 6():5. PubMed ID: 19222857
[TBL] [Abstract][Full Text] [Related]
15. Role of prostaglandin receptor subtype EP1 in prostaglandin E2-induced nociceptive transmission in the rat spinal dorsal horn.
Nakayama Y; Omote K; Kawamata T; Namiki A
Brain Res; 2004 Jun; 1010(1-2):62-8. PubMed ID: 15126118
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice.
Kitamura T; Itoh M; Noda T; Tani K; Kobayashi M; Maruyama T; Kobayashi K; Ohuchida S; Sugimura T; Wakabayashi K
Cancer Sci; 2003 Jul; 94(7):618-21. PubMed ID: 12841871
[TBL] [Abstract][Full Text] [Related]
17. Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development.
Abran D; Dumont I; Hardy P; Peri K; Li DY; Molotchnikoff S; Varma DR; Chemtob S
Circ Res; 1997 Apr; 80(4):463-72. PubMed ID: 9118476
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E receptor subtype EP1-selective antagonist, SC51089.
Matsuo M; Yoshida N; Zaitsu M; Ishii K; Hamasaki Y
J Neurooncol; 2004 Feb; 66(3):285-92. PubMed ID: 15015658
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney.
Morath R; Klein T; Seyberth HW; Nüsing RM
J Am Soc Nephrol; 1999 Sep; 10(9):1851-60. PubMed ID: 10477136
[TBL] [Abstract][Full Text] [Related]
20. Activation of calcitonin gene-related peptide signaling through the prostaglandin E2-EP1/EP2/EP4 receptor pathway in synovium of knee osteoarthritis patients.
Minatani A; Uchida K; Inoue G; Takano S; Aikawa J; Miyagi M; Fujimaki H; Iwase D; Onuma K; Matsumoto T; Takaso M
J Orthop Surg Res; 2016 Oct; 11(1):117. PubMed ID: 27751171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
